MCI Radiation Oncology Evaluation - May 15, 2026

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles.	Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles. - 5	Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles. - 4	Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles. - 3	Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles. - 2	Demonstrate the ability to critically evaluate and synthesize current clinical evidence supporting radiotherapy indications in Hodgkin lymphoma, including PET adapted strategies, involved site radiotherapy principles. - 1
Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making.	Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making. - 5	Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making. - 4	Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making. - 3	Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making. - 2	Identify and articulate the key gaps in current evidence and clinical understanding regarding the use of radiotherapy in Hodgkin lymphoma, including uncertainties in PET adapted decision making. - 1
Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum.	Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum. - 5	Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum. - 4	Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum. - 3	Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum. - 2	Explain the central role of survivorship in the management of Hodgkin lymphoma, demonstrating an understanding of how long term health risks, late treatment effects, and quality of life considerations shape therapeutic decision making, follow up care, and patient counseling across the survivorship continuum. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice

	5	4	3	2	1
identify radiotherapy indications for Hodgkin Lymphoma.	identify radiotherapy indications for Hodgkin Lymphoma. - 5	identify radiotherapy indications for Hodgkin Lymphoma. - 4	identify radiotherapy indications for Hodgkin Lymphoma. - 3	identify radiotherapy indications for Hodgkin Lymphoma. - 2	identify radiotherapy indications for Hodgkin Lymphoma. - 1
Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma.	Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma. - 5	Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma. - 4	Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma. - 3	Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma. - 2	Identify gaps in knowledge for radiotherapy use in Hodgkin Lymphoma. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name and ABS ID Required to claim MOC

You are here

MCI Radiation Oncology Evaluation - May 15, 2026